关注
Rikhav Gala
Rikhav Gala
Principal Scientist, Pfizer Inc
在 pfizer.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Microneedles: a new generation vaccine delivery system
I Menon, P Bagwe, KB Gomes, L Bajaj, R Gala, MN Uddin, MJ D’souza, ...
Micromachines 12 (4), 435, 2021
1082021
Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization
RP Gala, RU Zaman, MJ D’Souza, SM Zughaier
Vaccines 6 (3), 60, 2018
642018
Physicochemical and preclinical evaluation of a novel buccal measles vaccine
RP Gala, C Popescu, GT Knipp, RR McCain, RV Ubale, R Addo, ...
AAPS PharmSciTech 18, 283-292, 2017
632017
A comprehensive production method of self-cryoprotected nano-liposome powders
RP Gala, I Khan, AMA Elhissi, MA Alhnan
International Journal of Pharmaceutics 486 (1-2), 153-158, 2015
502015
Buccal and sublingual vaccines: A review on oral mucosal immunization and delivery systems
V Trincado, RP Gala, JO Morales
Vaccines 9 (10), 1177, 2021
312021
Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine
RP Gala, M D'Souza, SM Zughaier
Vaccine 34 (28), 3260-3267, 2016
252016
Novel ablative laser mediated transdermal immunization for microparticulate measles vaccine
D Joshi, RP Gala, MN Uddin, MJ D'Souza
International journal of pharmaceutics 606, 120882, 2021
202021
Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles
RV Ubale, RP Gala, SM Zughaier, MJ D’Souza
The AAPS journal 16, 986-993, 2014
202014
Novel approaches and strategies for biologics, vaccines and cancer therapies
MJ D’Souza, RP Gala, RV Ubale, B D’Souza, TP Vo, AC Parenky, ...
Elsevier Inc, 2015
182015
Novel approaches and strategies for biologics, vaccines and cancer therapies
M Singh, M Salnikova
Academic Press, 2014
172014
On-Demand and Tunable Dual Wavelength Release of Antibodies Using Light-Responsive Hydrogels
PJ LeValley, BP Sutherland, J Jaje, S Gibbs, RM Jones, RP Gala, ...
ACS applied bio materials 3 (10), 6944-6958, 2020
152020
Potential applications of microparticulate-based bacterial outer membrane vesicles (OMVs) vaccine platform for sexually transmitted diseases (STDs): gonorrhea, chlamydia, and …
C Chbib, SM Shah, RP Gala, MN Uddin
Vaccines 9 (11), 1245, 2021
122021
Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies
MJ D’Souza, RP Gala, RV Ubale, B D’Souza, TP Vo, AC Parenky, ...
Novel approaches and strategies for biologics, vaccines and cancer therapies …, 2015
102015
Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation
P Bagwe, L Bajaj, RP Gala, MJ D ‘Souza, SM Zughaier
Vaccines 10 (7), 983, 2022
92022
Development of Non-Conjugated Meningitis Particulate vaccine
RPG Ruhi V Ubale, Martin J D'Souza, Susu Zughaier
Nanoparticulate Vaccine Delivery Systems, 127, 2015
9*2015
Needleless administration of advanced therapies into the skin via the appendages using a hypobaric patch
F Benaouda, R Inacio, CH Lim, H Park, T Pitcher, MA Alhnan, MMS Aly, ...
Proceedings of the National Academy of Sciences 119 (18), e2120340119, 2022
82022
Nanoparticulate vaccine delivery systems
MJ D'Souza
CRC Press, 2015
72015
Preclinical evaluation of a microparticle-based transdermal vaccine patch against metastatic breast cancer
RU Zaman, RP Gala, A Bansal, P Bagwe, MJ D'Souza
International Journal of Pharmaceutics 627, 122249, 2022
62022
Microneedles: A New Generation Vaccine Delivery System. Micromachines 2021, 12, 435
I Menon, P Bagwe, KB Gomes, L Bajaj, R Gala, MN Uddin, MJ D’souza, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
42021
Meningococcal Vaccines: Challenges and Prospects
P Bagwe, L Bajaj, R Gala, SM Zughaier, MN Uddin, MJ D’Souza
Vaccines 8 (4), 738, 2020
42020
系统目前无法执行此操作,请稍后再试。
文章 1–20